Global University Venturing

Today, 1.3 million people die each year because of antimicrobial resistance, a figure that could increase to 10 million by 2050 — Strathclyde’s Microplate Dx hopes to prevent that.

What's going to happen to healthcare startup funding this year? Will the IPO market recover? And what kinds of technologies are on the up? We asked some leading CVCs for their view.

The $275m round, the largest series B for three months, featured several pharmaceutical companies and is part of a thriving environment for gene therapy startups.

Corporations are playing a bigger role in supporting new entrants to the venture industry.

Andy Naylor has left Nottingham Technology Ventures after five years as chief executive to become an investment director for Northern Gritstone.

Sustainability and customer experience are on the agenda for transportation CVCs in 2023.

Alexis Dormandy has reportedly been “forced out” and left the university venture fund shortly before Christmas.

Venture capital has poured into the cleantech sector over the past couple of years. Concerns are growing that startups may not be able to scale into viable companies that generate expected returns.

Take time, focus on quality and internal relationships, make an impact — these are the top resolutions investors have for 2023.

2022 saw a screeching turnaround in market sentiment. How well did corporate investors cope?

The number of $1bn plus CVC funds has increased, but most still work with less than $200m.